H
HOB Biotech Group Corp Ltd
SSE:688656
HOB Biotech Group Corp Ltd
SSE:688656
Price:
136.88
CNY
2.01%
Market Closed
Market Cap:
¥8.7B
Income Statement
Earnings Waterfall
HOB Biotech Group Corp Ltd
HOB Biotech Group Corp Ltd
Income Statement
HOB Biotech Group Corp Ltd
HOB Biotech Group Corp Ltd
Currency: CNY
| Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||
| Interest Expense |
1
|
1
|
0
|
2
|
2
|
3
|
0
|
3
|
3
|
3
|
0
|
3
|
3
|
0
|
0
|
|
| Revenue |
333
N/A
|
321
-3%
|
336
+5%
|
320
-5%
|
325
+1%
|
360
+11%
|
366
+2%
|
394
+8%
|
399
+1%
|
407
+2%
|
401
-1%
|
402
+0%
|
394
-2%
|
389
-1%
|
387
0%
|
|
| Gross Profit | ||||||||||||||||
| Cost of Revenue |
(109)
|
(112)
|
(123)
|
(118)
|
(128)
|
(142)
|
(144)
|
(149)
|
(152)
|
(153)
|
(153)
|
(145)
|
(153)
|
(157)
|
(163)
|
|
| Gross Profit |
223
N/A
|
209
-6%
|
214
+2%
|
202
-5%
|
197
-3%
|
217
+10%
|
222
+2%
|
245
+10%
|
247
+1%
|
253
+3%
|
248
-2%
|
257
+4%
|
242
-6%
|
232
-4%
|
224
-3%
|
|
| Operating Income | ||||||||||||||||
| Operating Expenses |
(134)
|
(145)
|
(159)
|
(159)
|
(165)
|
(176)
|
(183)
|
(191)
|
(193)
|
(197)
|
(205)
|
(212)
|
(198)
|
(199)
|
(193)
|
|
| Selling, General & Administrative |
(103)
|
(111)
|
(123)
|
(113)
|
(125)
|
(132)
|
(136)
|
(136)
|
(147)
|
(151)
|
(160)
|
(153)
|
(155)
|
(155)
|
(148)
|
|
| Research & Development |
(32)
|
(34)
|
(37)
|
(35)
|
(42)
|
(46)
|
(49)
|
(43)
|
(47)
|
(47)
|
(46)
|
(42)
|
(45)
|
(45)
|
(46)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
(11)
|
0
|
0
|
0
|
(13)
|
0
|
0
|
0
|
(18)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
2
|
1
|
1
|
1
|
2
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Operating Income |
90
N/A
|
65
-28%
|
55
-15%
|
43
-22%
|
32
-25%
|
41
+28%
|
39
-5%
|
54
+39%
|
54
-2%
|
56
+4%
|
44
-22%
|
45
+3%
|
43
-4%
|
33
-23%
|
32
-5%
|
|
| Pre-Tax Income | ||||||||||||||||
| Interest Income Expense |
10
|
8
|
7
|
5
|
5
|
3
|
1
|
1
|
0
|
(1)
|
(1)
|
(2)
|
(3)
|
(2)
|
(2)
|
|
| Non-Reccuring Items |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
7
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
|
| Total Other Income |
2
|
2
|
2
|
(1)
|
(1)
|
(1)
|
(0)
|
1
|
1
|
(0)
|
(0)
|
0
|
(0)
|
0
|
1
|
|
| Pre-Tax Income |
101
N/A
|
75
-26%
|
64
-15%
|
46
-27%
|
36
-23%
|
44
+23%
|
40
-8%
|
57
+41%
|
55
-3%
|
55
+0%
|
42
-23%
|
41
-3%
|
39
-4%
|
30
-23%
|
37
+23%
|
|
| Net Income | ||||||||||||||||
| Tax Provision |
(15)
|
(9)
|
(8)
|
(5)
|
(2)
|
(5)
|
(4)
|
(9)
|
(9)
|
(9)
|
(7)
|
(4)
|
(5)
|
(1)
|
(1)
|
|
| Income from Continuing Operations |
86
|
65
|
56
|
42
|
34
|
39
|
36
|
47
|
46
|
46
|
35
|
37
|
35
|
29
|
36
|
|
| Net Income (Common) |
86
N/A
|
65
-24%
|
56
-15%
|
42
-26%
|
34
-19%
|
39
+15%
|
36
-8%
|
47
+32%
|
46
-4%
|
46
+0%
|
35
-23%
|
37
+4%
|
35
-6%
|
29
-16%
|
36
+26%
|
|
| EPS (Diluted) |
1.38
N/A
|
1.03
-25%
|
0.88
-15%
|
0.66
-25%
|
0.53
-20%
|
0.61
+15%
|
0.57
-7%
|
0.75
+32%
|
0.72
-4%
|
0.73
+1%
|
0.56
-23%
|
0.58
+4%
|
0.55
-5%
|
0.45
-18%
|
0.6
+33%
|
|
Switch to:
Switch to:
See Also
Discover More
